Ozempic carries an increased risk of vision loss, but one similar drug is even five times more dangerous

Patients taking Wegovy are five times more at risk of sudden vision loss compared to those taking Ozempic, a new large study has shown.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

jutarnji-listSerbian159d ago

Ozempic nosi povećani rizik od gubitka vida, ali jedan sličan lijek čak je pet puta opasniji

Pacijenti koji uzimaju Wegovy u pet su puta većem riziku od iznenadnog gubitka vida u odnosu na one koji uzimaju Ozempic, pokazala je nova velika studija. Lijekovi koji se vežu na receptore glukagonu sličnog peptida-1 (GLP-1 RA), poput semaglutida (prodaje se kao Wegovy, Ozempic i Rybelsus) i tirzep...

Read full article →

PERSPECTA

PERSPECTA

Ozempic carries an increased risk of vision loss, but one similar drug is even five times more dangerous

Sources

Ozempic nosi povećani rizik od gubitka vida, ali jedan sličan lijek čak je pet puta opasniji

Related Stories

West Nile Fever Cases and Fatalities Reported in Serbia and North Macedonia

Metro Manila Inundated by Heavy Monsoon Rains

AstraZeneca Halts Lung Cancer Drug Trial

Priessnitz Spa Addresses Outbreak of Digestive Problems, Hygiene Registers 111 Cases

PERSPECTA